Filana Therapeutics (SAVA) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q3 2024
Q1 2025
Q2 2025
-0.88
-0.54
-0.21
0.13

Details

Expected EPS
N/A
Actual EPS
-0.48
Surprise EPS
-0.48
Surprise Percent
+∞%

Description

Filana Therapeutics (SAVA) has reported earnings of -0.48 per share for Q2 2025.

0 Comments

Share your thoughts